The combination of different discovery technologies is of importance to obtain mAbs targeted against difficult antigens and rare functional epitopes. Advanced antibody lead optimization by ...

B-cells were collected from people with and without MS, and those from patients had heightened antibody responses, ...

Ideally, these antigens are expressed at minimal levels ... 2007). Furthermore, an antibody directed against extracellular rather than cell-surface mucin, which was conjugated via an acid-labile ...

have designed a synthetic compound (antigen) that can latch on to a protein in blood and hitchhike a ride to the lymph node, where it can boost the production of antibodies against cancer cells ...

Antibodies bind to specific antigens on pathogens. This means that only one type of antibody will bind to a matching antigen. For example, an antibody that can recognise an antigen on the ...

Antibodies bind to specific antigens on pathogens. This means that only one type of antibody will bind to a matching antigen. Scientists discovered that we could make antibodies to bind to ...

The global market for anticancer monoclonal antibodies (MAbs) was valued at approximately USD $$ billion in 2022 and is projected to exhibit a robust growth rate of over $% during the forecast period ...